New antibodies against LPHN2 developed in-house

New antibodies against LPHN2 developed in-house
Custom antibody discovery 🧪 ➡️ Expert validation ✅ ➡️ Shared with the scientific community 🤝

We’re excited to announce the addition of two new antibodies against LPHN2 to our catalogue:
ABCD_RB910 – targeting an intracellular epitope
ABCD_RB905 – targeting an extracellular epitope
Both validated for IF 🔬

Latrophilin-2 is an adhesion G protein-coupled receptor, best known for its role in neuronal development and synapse formation 🧠 .

These new reagents are the result of a close collaboration with an academic partner who commissioned a custom antibody discovery campaign. Using Phage Display, we identified multiple candidates targeting different epitopes of LPHN2.

Two antibodies were then rigorously validated by the researcher and their results published in AntibodyReports.
https://oap.unige.ch/journals/abrep/article/view/2218

Today, ABCD Antibodies is making these validated antibodies available to the entire scientific community. Turning a tailored project into widely accessible research tools.
A great example of how collaboration drives better science.

Antibodies PhageDisplay LifeSciences Biotech Collaboration ResearchTools
Share
abstract